Skip to main content
ArticleOPEN ACCESS

Correction to: REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal (Neurological Sciences, (2020), 10.1007/s10072-020-04726-6)

Neurological Sciences
DOI: 10.1007/s10072-020-04879-4
0Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The article “REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal”.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Batista, S., Nunes, C. C., Cerqueira, J. J., Silva, A. M., de Sá, J. C., Ferreira, J., … Sousa, L. (2021, February 1). Correction to: REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal (Neurological Sciences, (2020), 10.1007/s10072-020-04726-6). Neurological Sciences. Springer-Verlag Italia s.r.l. https://doi.org/10.1007/s10072-020-04879-4

Readers' Seniority

Tooltip

Professor / Associate Prof. 1

50%

PhD / Post grad / Masters / Doc 1

50%

Readers' Discipline

Tooltip

Medicine and Dentistry 1

33%

Business, Management and Accounting 1

33%

Neuroscience 1

33%

Save time finding and organizing research with Mendeley

Sign up for free